Notes to financial statements ------------------------- Annual report 2000 - contents ------------------------- Financial summary ------------------------- Joint statement by the Chairman & the CEO ------------------------- Description of business ------------------------- Corporate Governance ------------------------- Remuneration Report ------------------------- Operating & Financial Review & Prospects ------------------------- Directors' statements of responsibility ------------------------- Report by the auditors ------------------------- Consolidated statement of profit & loss ------------------------- Consolidated statement of total recognised gains & losses ------------------------- Consolidated statement of cash flow ------------------------- Consolidated balance sheet ------------------------- Reconciliation of movements in equity shareholders' funds ------------------------- Company balance sheet ------------------------- Notes to financial statements ------------------------- Group companies ------------------------- Principal financial statements in US$ ------------------------- Financial record ------------------------- Shareholder Return ------------------------- Taxation information for shareholders ------------------------- Shareholder information ------------------------- Share capital ------------------------- Cross reference to Form 20-F ------------------------- Glossary of terms ------------------------- Contact details
1. Presentation of financial statements 2. Post balance sheet event 3. Accounting policies 4. New accounting policies and requirements 5. Exchange rates 6. Merger of Glaxo Wellcome and SmithKline Beecham 7. Segment Information 8. Merger items, restructuring costs and divested businesses 9. Other operating income/(expense) 10. Operating profit 11. Joint ventures and associated undertakings 12. Net interest payable 13. Taxation 14. Earnings per Ordinary Share 15. Dividends 16. Goodwill 17. Intangible assets 18. Tangible fixed assets 19. Fixed asset investments 20. Equity investments 21. Stocks 22. Debtors 23. Other creditors 24. Provisions for liabilities and charges 25. Contingent liabilities 26. Net debt 27. Commitments 28. Share capital and share premium account 29. Non-equity minority interest 30. Other reserves 31. Legal proceedings 32. Acquisitions and disposals 33. Employee share schemes 34. Financial instruments and related disclosures 35. Employee costs 36. Directors' remuneration 37. Reconciliation to US accounting principles     Back to top Updated March 22, 2001 - © 2001-2002 GlaxoSmithKline - All Rights Reserved Legal Notices - Privacy Statement